Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: Brazil Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20183
20191
20224
20235
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Withdrawn2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Eli Lilly and Company4
Sanofi4
Pfizer2
AbbVie1
Applied Biology, Inc.1
Azidus Brasil1
EMS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic19
Eczema9
Dermatitis3
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1
Immune System Diseases1
Skin Diseases1
Skin Diseases, Eczematous1
Skin Diseases, Genetic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.